Edward J. Benz JR - 21 Jun 2023 Form 4 Insider Report for Deciphera Pharmaceuticals, Inc. (DCPH)

Role
Director
Signature
/s/ Jeffrey M. Held, Attorney-in-Fact
Issuer symbol
DCPH
Transactions as of
21 Jun 2023
Net transactions value
$0
Form type
4
Filing time
23 Jun 2023, 16:05:27 UTC
Previous filing
05 Dec 2022
Next filing
29 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DCPH Stock Option (Right to Buy) Award $0 +30,000 $0.000000 30,000 21 Jun 2023 Common Stock 30,000 $14.91 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan. The option shall vest in full on June 21, 2024, subject to continued service through such date.